Labasia Bio-Medicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.19 Cr
- Revenue Growth -10.13%
- Profit Growth -8.63%
- Ebitda 23.60%
- Net Worth 59.07%
- Total Assets 69.55%
About Labasia Bio-Medicals
Labasia Bio-Medicals Private Limited (LBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 February 2015 (Nine years and 11 months 11 days old ). Its registered office is in Hanumangarh, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.19 Cr.
Kamal Preet, Sita Ram, and Tony Aggarwal serve as directors at the Company.
Company Details
- Location
Hanumangarh, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900RJ2015PTC047073
- Company No.
047073
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
What products or services does Labasia Bio-Medicals Private Limited offer?
Labasia Bio-Medicals Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Biochemistry Analyzer, Microscope, Binocular Microscope, Clinical Reagents, IVDs & Analyzers, Hematology Analyzers, Metallurgical & Lab Microscopes, Laboratory Microscope, Laboratory Centrifuge.
Who are the key members and board of directors at Labasia Bio-Medicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamal Preet  | Director | 20-Feb-2015 | Current |
| Sita Ram | Director | 20-Feb-2015 | Current |
| Tony Aggarwal | Director | 20-Feb-2015 | Current |
Financial Performance of Labasia Bio-Medicals.
Labasia Bio-Medicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.13% decrease. The company also saw a slight decrease in profitability, with a 8.63% decrease in profit. The company's net worth Soared by an impressive increase of 59.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Labasia Bio-Medicals?
Unlock access to Labasia Bio-Medicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹31.89 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 May 2023 | Others | ₹2.58 M | Open |
| 04 Aug 2017 | Others | ₹2.93 Cr | Open |
How Many Employees Work at Labasia Bio-Medicals?
Unlock and access historical data on people associated with Labasia Bio-Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labasia Bio-Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labasia Bio-Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.